Clinical Studies with Methyl-dopa (Aldomet®) in Patients with Hypertension During Two Years
- 24 April 2009
- journal article
- research article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 174 (2) , 183-192
- https://doi.org/10.1111/j.0954-6820.1963.tb07910.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension∗The American Journal of Cardiology, 1962
- ALPHA METHYL DOPA IN TREATMENT OF HYPERTENSIONThe Lancet, 1962
- Clinical and Chemical Studies with α -Methyl-Dopa in Patients with HypertensionCirculation, 1962
- Hemodynamic Effects of Methyldopa (Aldomet®) at Rest and during Exercise in Patients with Arterial HypertensionActa Medica Scandinavica, 1962
- Pharmacodynamics and clinical use of guanethidine, bretylium and methyldopaThe American Journal of Cardiology, 1962
- Monoamine Oxidase and Decarboxylase Inhibitors as Antihypertensive AgentsMedical Clinics of North America, 1961
- Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineScience, 1960
- Hemmung der Dopadecarboxylase durch ?-Methyldopa in vivoNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1958
- Some Different Types Of Essential HypertensionThe Lancet Healthy Longevity, 1939
- Cardiovascular Changes in essential HypertensionActa Medica Scandinavica, 1939